LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 77 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $60,000 | -50.4% | 14,343 | +9.0% | 0.00% | – |
| Q3 2019 | $121,000 | -0.8% | 13,158 | 0.0% | 0.00% | – |
| Q2 2019 | $122,000 | -73.7% | 13,158 | -17.2% | 0.00% | -100.0% |
| Q2 2018 | $463,000 | +19.6% | 15,882 | +22.1% | 0.00% | – |
| Q1 2018 | $387,000 | -8.7% | 13,004 | -1.4% | 0.00% | – |
| Q4 2017 | $424,000 | -5.6% | 13,190 | +2.0% | 0.00% | -100.0% |
| Q3 2017 | $449,000 | +12.5% | 12,927 | -3.5% | 0.00% | – |
| Q2 2017 | $399,000 | +19.1% | 13,397 | +19.2% | 0.00% | – |
| Q1 2017 | $335,000 | +91.4% | 11,235 | +12.1% | 0.00% | – |
| Q4 2016 | $175,000 | -25.8% | 10,024 | +1.3% | 0.00% | – |
| Q3 2016 | $236,000 | +52.3% | 9,897 | +2.5% | 0.00% | – |
| Q2 2016 | $155,000 | -8.8% | 9,654 | +10.6% | 0.00% | – |
| Q1 2016 | $170,000 | -19.8% | 8,726 | +10.9% | 0.00% | – |
| Q4 2015 | $212,000 | +2.4% | 7,866 | +5.9% | 0.00% | – |
| Q3 2015 | $207,000 | +11.9% | 7,426 | -1.9% | 0.00% | – |
| Q2 2015 | $185,000 | – | 7,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $102,697,000 | 37.12% |
| RTW INVESTMENTS, LP | 1,028,929 | $30,714,000 | 8.08% |
| Consonance Capital Management LP | 1,420,742 | $42,409,000 | 4.44% |
| Perceptive Advisors | 2,139,274 | $63,857,000 | 3.64% |
| Broadfin Capital, LLC | 782,887 | $23,369,000 | 2.83% |
| Crawford Lake Capital Management, LLC | 171,373 | $5,115,000 | 2.03% |
| Crawford Lake Capital Management, LLC | 162,600 | $4,380,000 | 1.74% |
| ISZO CAPITAL MANAGEMENT LP | 30,967 | $924,000 | 1.61% |
| FT Options LLC | 33,141 | $989,000 | 1.30% |
| Monashee Investment Management LLC | 100,000 | $2,985,000 | 1.20% |